Pluton Biosciences, with the slogan "Micromining Nature's Solutions," was founded in 2017 in the United States. The company's innovative approach involves the extraction of natural resources, focusing on the microbial diversity in soil. Their platform, Micromining, rapidly identifies microbial leads for the development of next-generation biosolutions such as biopesticides and antibiotics. This groundbreaking technology has attracted significant attention, with the latest milestone being a $16.50M Series A investment on 24 May 2023, led by a consortium of prominent investors including RA Capital Management, Fall Line Capital, Illumina Ventures, Grantham Environmental Trust's Neglected Climate Opportunities Fund, iSelect, Radicle Growth, First In Ventures, and Wollemi. Pluton's commitment to addressing global challenges through their Micromining platform positions them as a notable player in the biotechnology and pharmaceutical industries. Their dedication to sustainability and impactful solutions underscores their potential to make a significant mark in the market. [Source: [Pluton Biosciences](https://plutonbio.box.com/s/1edxw6eduv2igz0qbcb3jahca277iclq)]
No recent news or press coverage available for Pluton Biosciences.